Diagnostic significance of secondary bacteremia in patients with COVID-19
Kensuke Nakagawara,Hirofumi Kamata,Shotaro Chubachi,Ho Namkoong,Hiromu Tanaka,Ho Lee,Shiro Otake,Takahiro Fukushima,Tatsuya Kusumoto,Atsuho Morita,Shuhei Azekawa,Mayuko Watase,Takanori Asakura,Katsunori Masaki,Makoto Ishii,Akifumi Endo,Ryuji Koike,Hiroyasu Ishikura,Tohru Takata,Yasushi Matsushita,Norihiro Harada,Hiroyuki Kokutou,Takashi Yoshiyama,Kensuke Kataoka,Yoshikazu Mutoh,Masayoshi Miyawaki,Soichiro Ueda,Hiroshi Ono,Takuya Ono,Tomohisa Shoko,Hiroyuki Muranaka,Kodai Kawamura,Nobuaki Mori,Takao Mochimaru,Mototaka Fukui,Yusuke Chihara,Yoji Nagasaki,Masaki Okamoto,Masaru Amishima,Toshio Odani,Mayuko Tani,Koichi Nishi,Yuya Shirai,Ryuya Edahiro,Akira Ando,Naozumi Hashimoto,Shinji Ogura,Yuichiro Kitagawa,Toshiyuki Kita,Takashi Kagaya,Yasuhiro Kimura,Naoki Miyazawa,Tomoya Tsuchida,Shigeki Fujitani,Koji Murakami,Hirohito Sano,Yuki Sato,Yoshinori Tanino,Ryo Otsuki,Shuko Mashimo,Mizuki Kuramochi,Yasuo Hosoda,Yoshinori Hasegawa,Tetsuya Ueda,Yotaro Takaku,Takashi Ishiguro,Akiko Fujiwara,Naota Kuwahara,Hideya Kitamura,Eri Hagiwara,Yasushi Nakamori,Fukuki Saito,Yuta Kono,Shinji Abe,Tomoo Ishii,Takehiko Ohba,Yu Kusaka,Hiroko Watanabe,Makoto Masuda,Hiroki Watanabe,Yoshifumi Kimizuka,Akihiko Kawana,Yu Kasamatsu,Satoru Hashimoto,Yukinori Okada,Tomomi Takano,Kazuhiko Katayama,Masumi Ai,Atsushi Kumanogoh,Toshiro Sato,Katsushi Tokunaga,Seiya Imoto,Yuko Kitagawa,Akinori Kimura,Satoru Miyano,Naoki Hasegawa,Seishi Ogawa,Takanori Kanai,Koichi Fukunaga,Japan COVID-19 Task Force
DOI: https://doi.org/10.1016/j.jiac.2023.01.006
Abstract:Objectives: We investigated the occurrence of non-respiratory bacterial and fungal secondary infections, causative organisms, impact on clinical outcomes, and association between the secondary pathogens and mortality in hospitalized patients with coronavirus disease 2019 (COVID-19). Methods: This was a retrospective cohort study that included data from inpatients with COVID-19 from multiple centers participating in the Japan COVID-19 Taskforce (April 2020 to May 2021). We obtained demographic, epidemiological, and microbiological data throughout the course of hospitalization and analyzed the cases of COVID-19 complicated by non-respiratory bacterial infections. Results: Of the 1914 patients included, non-respiratory bacterial infections with COVID-19 were diagnosed in 81 patients (4.2%). Of these, 59 (3.1%) were secondary infections. Bacteremia was the most frequent bacterial infection, occurring in 33 cases (55.9%), followed by urinary tract infections in 16 cases (27.1%). Staphylococcus epidermidis was the most common causative organism of bacteremia. Patients with COVID-19 with non-respiratory secondary bacterial infections had significantly higher mortality, and a multivariate logistic regression analysis demonstrated that those with bacteremia (aOdds Ratio = 15.3 [5.97-39.1]) were at higher risk of death. Multivariate logistic regression analysis showed that age, male sex, use of steroids to treat COVID-19, and intensive care unit admission increased the risk for nosocomial bacteremia. Conclusions: Secondary bacteremia is an important complication that may lead to poor prognosis in cases with COVID-19. An appropriate medical management strategy must be established, especially for patients with concomitant predisposing factors.